Cancer-associated fibroblasts confer cisplatin resistance of tongue cancer via autophagy activation
Authors:
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 97, 1341-1348
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81600899)
- National Natural Science Foundation of China (81702695)
- National Natural Science Foundation of China (81772888)
This publication has 35 references indexed in Scilit:
- Randomized Phase III Trial of Induction Chemotherapy With Docetaxel, Cisplatin, and Fluorouracil Followed by Surgery Versus Up-Front Surgery in Locally Advanced Resectable Oral Squamous Cell CarcinomaJournal of Clinical Oncology, 2013
- Cancer‐associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patientsCancer Science, 2013
- BCL2L11/BIMAutophagy, 2013
- MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1Oncogene, 2011
- Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cellsBMC Cancer, 2010
- Chloroquine and its analogs: A new promise of an old drug for effective and safe cancer therapiesEuropean Journal of Pharmacology, 2009
- Autophagy in the Pathogenesis of DiseaseCell, 2008
- Randomized Phase III Evaluation of Cisplatin Plus Fluorouracil Versus Cisplatin Plus Paclitaxel in Advanced Head and Neck Cancer (E1395): An Intergroup Trial of the Eastern Cooperative Oncology GroupJournal of Clinical Oncology, 2005
- Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 SecretionCell, 2005
- Stromal fibroblasts in cancer initiation and progressionNature, 2004